| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/26/2007 | WO2007059166A3 Peptide sequence that promotes tumor invasion |
| 07/26/2007 | WO2007056441A3 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| 07/26/2007 | WO2007051836A3 Compositions for treating dermatological and neurological disorders |
| 07/26/2007 | WO2007047578A3 Cell display of antibody libraries |
| 07/26/2007 | WO2007042573A3 Compositions and methods for treating proliferative disorders |
| 07/26/2007 | WO2007031222A3 Identification of tumor-associated antigens for diagnosis and therapy |
| 07/26/2007 | WO2007025166A3 Devices, compositions and methods for the protection and repair of cells and tissues |
| 07/26/2007 | WO2006130527A3 Mutations and polymorphisms of fibroblast growth factor receptor 1 |
| 07/26/2007 | WO2006110745A3 Conjugated anti-psma antibodies |
| 07/26/2007 | WO2006084264A3 Cd20 antibody variants and uses thereof |
| 07/26/2007 | WO2006083331A3 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/26/2007 | WO2006069036A3 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 07/26/2007 | WO2005051998A3 Antibodies binding to a c-terminal fragment of apolipoprotein e |
| 07/26/2007 | WO2004090097A3 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174923 Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS) |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173638 Purification process of gamma-globulins from human plasma and other sources; using caprylate combined with or replaced by heptanoate to perform precipitation and incubation; anion exchange chromatography |
| 07/26/2007 | US20070173439 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172918 Non aggregating fluorescent proteins and methods for using the same |
| 07/26/2007 | US20070172895 Flow cytometry; measuring binding efficiency of L104EA29YIg to CD86 or CD80 receptors by comparing the binding of non-competing anti-CD86 or CD80 monoclonal antibodies to CD86 or CD80 receptors; lysing blood sample and fixing leukocytes; measuring receptor expression; transplant rejection; immunology |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172887 Monoclonal antibody based biomarker discovery and development platform |
| 07/26/2007 | US20070172880 Transient Receptor Potential Channels is an emerging class of Ca2+-permeable cation channel superfamily; for diagnosis, treatment, and/or prevention of various diseases |
| 07/26/2007 | US20070172870 Method for diagnosing selected adenocarcinomas |
| 07/26/2007 | US20070172817 Methods of Producing Antibodies for Diagnostics and Therapeutics |
| 07/26/2007 | US20070172544 Method of quickly measuring factor causing early flocculation of yeast |
| 07/26/2007 | US20070172500 Anthrax antitoxins |
| 07/26/2007 | US20070172497 BoNT/A PEPTIDES AND METHODS OF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY |
| 07/26/2007 | US20070172496 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172488 cell proliferation-inhibiting activity by ADCC (antibody-dependent cell-mediated cytotoxicity) activity and CDC (complement-dependent cytotoxicity); hepatic cancer |
| 07/26/2007 | US20070172487 Alpha-enolase specific antibody and method of use |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172485 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172482 using a hapten comprising tetracarboxy phenyl porphyrin zinc or cobalt complexes, to generate monoclonal or polyclonal antibodies and testing for inhibitory effects of the antibodies on the gelatinase B; metalloenzyme inhibitors |
| 07/26/2007 | US20070172481 GDF3 propeptides and related methods |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172475 Highly concentrated, liquid formulations of anti-egfr antibodies |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172457 Interleukins-21 and 22 |
| 07/26/2007 | US20070172456 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 07/26/2007 | US20070172423 Composition and method for modulating vasculogenesis for angiogenesis |
| 07/26/2007 | CA2675534A1 Mutant jak3 kinase in human leukemia |
| 07/26/2007 | CA2637719A1 C-terminal exon 5.4 of runx1/aml1 |
| 07/26/2007 | CA2637697A1 Means and methods for modulating stem cell mobilization |
| 07/26/2007 | CA2637254A1 Compositions and methods for humanization and optimization of n-glycans in plants |
| 07/26/2007 | CA2637252A1 Plants and plant cells having inhibited expression of .alpha.1,3-fucosyltransferase and .beta.1,2-xylosyltransferase |
| 07/26/2007 | CA2636577A1 Antibodies to ox-2/cd200 and uses thereof |
| 07/26/2007 | CA2636566A1 A novel surface exposed haemophilus influenzae protein (protein e; pe) |
| 07/26/2007 | CA2636492A1 Method for measuring cholesterol in remnant-like lipoprotein |
| 07/26/2007 | CA2612467A1 Bispecific single chain fv antibody molecules and methods of use thereof |
| 07/25/2007 | EP1811304A1 Large Aß-peptide binding particles (LAPS) in diagnosis and therapy of Alzheimer's dementia |
| 07/25/2007 | EP1811042A2 cDNA synthesis improvements |
| 07/25/2007 | EP1811039A1 Method of efficiently screening protein capable of specific binding to ligand |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811032A1 C-terminal exon 5.4 of RUNX1/AML1 |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811023A1 Gene expressed specifically in es cells and utilization of the same |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810980A1 Interleukin-6 inhibitors |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810978A2 Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof |
| 07/25/2007 | EP1810690A1 Remedy for endometriosis |
| 07/25/2007 | EP1810686A1 Means and methods for modulating stem cell mobilization |
| 07/25/2007 | EP1810035A2 Engineering fc antibody regions to confer effector function |
| 07/25/2007 | EP1810029A1 Topiramate analogs |
| 07/25/2007 | EP1809761A2 Compositions and methods for modulating dhr96 |
| 07/25/2007 | EP1809673A2 Modulators of hepatocyte growth factor activator |
| 07/25/2007 | EP1809672A1 Atazanavir conjugates and antibibodies useful in immunossay |
| 07/25/2007 | EP1809671A2 Targeted innate immunity |
| 07/25/2007 | EP1809670A2 Irta-4 antibodies and their uses |
| 07/25/2007 | EP1809326A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 07/25/2007 | EP1809324A2 Methods to treat or prevent viral-associated lymphoproliferative disorders |
| 07/25/2007 | EP1809098A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 07/25/2007 | EP1319184B1 Use of antibodies against specific mhc-peptide complexes |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | EP0676965B1 Method of reducing immunogenicity of variable region of antibodies |
| 07/25/2007 | EP0665888B2 Ryegrass pollen allergen |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328379C Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity |
| 07/25/2007 | CN1328286C Aglyco products and method of use |
| 07/25/2007 | CN1327896C Compositions and method for treating viral infections |
| 07/25/2007 | CN101006176A Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 07/25/2007 | CN101006100A Optimized dosing with anti-CD4 antibodies for tolerance induction in primates |
| 07/25/2007 | CN101005854A Method for augmenting B cell depletion |
| 07/25/2007 | CN101003811A Citron gene of human, coding protein, and application |
| 07/25/2007 | CN101003805A C100F58 gene of human, its coding proteins, and application |
| 07/25/2007 | CN101003804A Method for preparing and purifying antigen with multiple epitopes of E protein of hog cholera virus |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003572A Monoclonal antibody of immunoglobulin of anti lymphocyst vitos of Pacific fluke, and preparation method |
| 07/25/2007 | CN101002936A Vaccine for preventing flavivirus infection |
| 07/25/2007 | CN101002549A Transgenic non-human animals capable of producing heterologous antibodies |
| 07/24/2007 | US7247718 Polypeptide which is not expressed on normal, mature myeloid cells, for isolating cell suspensions from human blood and marrow for use in bone marrow transplantation, gene therapy and in treating diseases |